Skip to search formSkip to main contentSkip to account menu

Benign prostatic hypertrophy

Known as: Benign hypertrophy of prostate NOS, prostate hypertrophy, Ipertrofia prostatica benigna 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The action of transforming growth factor β (TGF‐β) is mediated through type 1 (TβRI) and type 2 (TβRII) receptors. Prostate… 
Review
1997
Review
1997
The treatment of BPH by alpha blockade is built upon a sound anatomical, physiological and pharmacological rationale. The theory… 
1990
1990
Local deep microwave hyperthermia has been introduced recently for the treatment of benign prostatic hypertrophy (BPH). We report… 
1988
1988
The symptoms of 128 consecutive patients (mean age 65 years) with benign prostatic hypertrophy were assessed and compared with… 
Review
1988
Review
1988
Although the symptoms of benign prostatic hyperplasia are usually attributed to simple mechanical obstruction of the prostatic… 
1987
1987
Retrograde transurethral balloon dilation of the prostatic urethra was performed in five human volunteers with benign prostatic… 
Highly Cited
1985
Highly Cited
1985
The absorption changes that occur in reaction centers of the photosynthetic bacterium Rhodopseudomonas sphaeroides during the… 
Highly Cited
1976
Highly Cited
1976
5 alpha-Dihydrotestosterone (DHT) and androstanediols (diols) have been measured in human prostate tissue. DHT levels in surgical… 
1969
1969
Eleven patients with benign prostatic hypertrophy (BPH) and urinary retention requiring catheter drainage in all cases except one…